SIGN UP
LOG IN
News
Zylox-Tonbridge Medical Technology
--
--
0.00%
Zylox-Tonbridge Announces Share Repurchase of 50,000 Shares at HKD 1,018,565 in HKEX Filing
Reuters · 21h ago
Zylox-Tonbridge Medical Technology Announces New Share Award Scheme for Service Providers
Reuters · 1d ago
Zylox-Tonbridge Announces Share Repurchase of 50,000 Shares for HKD 1,007,565 in HKEX Filing
Reuters · 1d ago
Zylox-Tonbridge Medical Technology Announces Share Repurchase in HKEX Filing: 1,332,500 Shares at HKD 996,300
Reuters · 2d ago
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0707-0711)?
Weekly Report · 3d ago
Zylox-Tonbridge Files Next Day Disclosure to HKEX: Announces Repurchase of 1,282,500 Shares for HKD 987,875
Reuters · 5d ago
Zylox-Tonbridge Announces Next Day Disclosure to HKEX: Repurchases 1,232,500 Shares for HKD 983,990
Reuters · 6d ago
Zylox-Tonbridge Medical Tech Files Next Day Disclosure Return to HKEX, Announces Repurchase of 1,182,500 Shares at HKD 992,500
Reuters · 07/09 11:29
Zylox-Tonbridge Medical Files Next Day Disclosure with HKEX: Announces Repurchase of 1,132,500 Shares for HKD 992,185
Reuters · 07/08 11:08
Zylox-Tonbridge Files Next Day Disclosure to HKEX Announcing Repurchase of 50,000 Shares for HKD 1,025,550
Reuters · 07/07 09:38
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0630-0704)?
Weekly Report · 07/06 22:00
Zylox-Tonbridge Files Disclosure to HKEX on Repurchase of 50,000 Shares for HKD 1,039,350
Reuters · 07/04 11:24
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0623-0627)?
Weekly Report · 06/29 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0616-0620)?
Weekly Report · 06/22 22:00
Has Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Simply Wall St · 06/19 23:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0609-0613)?
Weekly Report · 06/15 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0602-0606)?
Weekly Report · 06/08 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0526-0530)?
Weekly Report · 06/01 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0519-0523)?
Weekly Report · 05/25 22:00
Here's Why Shareholders May Want To Be Cautious With Increasing Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) CEO Pay Packet
Simply Wall St · 05/23 22:42
About Zylox-Tonbridge Medical Technology
Zylox-Tonbridge Medical Technology Co Ltd is a China-based company mainly engaged in the manufacture of neurological and peripheral vascular interventional devices. The Company's main business is to provide medical devices for the treatment and treatment of neurological and peripheral vascular diseases for doctors and patients. The main products are Phoenix Neurovascular Embolization Coil, Thrombite Clot Retriever Device, White Horse Intracranial Balloon Catheter, as well as UltraFree Drug-coated PTA Balloon Catheter, ZENFLOW PTA Balloon Catheter and ZENFLOW High Pressure PTA Balloon Catheter.
MoreRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.